OmniAb, Inc. (OABI)
Largest Insider Buys in Sector
OABI Stock Price History Chart
OABI Stock Performance
About OmniAb, Inc.
OmniAb, Inc., a biotechnology company, provides therapeutic antibody discovery technologies in the United States. The company's discovery platform provides industry partners access to the diverse antibody repertoires and screening technologies to enable discovery of next-generation therapeutics. Its OmniAb platform is the biological intelligence of proprietary transgenic animals, including OmniRat, OmniChicken, and OmniMouse that have been genetically modified to generate antibodies with human sequences to facilitate development of human …
Insider Activity of OmniAb, Inc.
Over the last 12 months, insiders at OmniAb, Inc. have bought $2.23M and sold $326,017 worth of OmniAb, Inc. stock.
On average, over the past 5 years, insiders at OmniAb, Inc. have bought $2.95M and sold $280,509 worth of stock each year.
Highest buying activity among insiders over the last 12 months: FOEHR MATTHEW W (President and CEO) — $8.91M.
The last purchase of 240,000 shares for transaction amount of $1.06M was made by FOEHR MATTHEW W (President and CEO) on 2024‑05‑24.
List of Insider Buy and Sell Transactions, OmniAb, Inc.
| 2024-12-09 | Sale | President and CEO | 13,634 0.0113% | $4.13 | $56,308 | -6.65% | ||
| 2024-12-09 | Sale | Chief Legal Officer | 8,022 0.0067% | $4.13 | $33,131 | -6.65% | ||
| 2024-12-09 | Sale | Executive VP, Finance and CFO | 23,871 0.0199% | $4.13 | $98,587 | -6.65% | ||
| 2024-05-24 | President and CEO | 240,000 0.2109% | $4.42 | $1.06M | -5.13% | |||
| 2024-04-08 | Sale | Chief Legal Officer | 6,954 0.0059% | $5.27 | $36,648 | -19.49% | ||
| 2024-04-08 | Sale | Executive VP, Finance and CFO | 6,954 0.0059% | $5.27 | $36,648 | -19.49% | ||
| 2024-04-01 | Sale | Executive VP, Finance & CFO | 11,849 0.0103% | $5.46 | $64,696 | -19.96% | ||
| 2024-03-22 | President and CEO | 225,000 0.1948% | $5.19 | $1.17M | -16.02% | |||
| 2023-12-12 | Chief Executive Officer | 200,000 0.1722% | $5.05 | $1.01M | -8.93% | |||
| 2023-11-10 | President and CEO | 95,000 0.0821% | $4.27 | $405,517 | +9.31% | |||
| 2023-08-14 | President and CEO | 45,000 0.0391% | $5.48 | $246,600 | -6.79% | |||
| 2023-06-09 | Chief Executive Officer | 115,000 0.1157% | $4.52 | $519,800 | +14.35% | |||
| 2023-05-23 | Sale | director | 9,000 0.0085% | $4.05 | $36,450 | +19.95% | ||
| 2023-05-19 | Sale | director | 1,000 0.0011% | $4.05 | $4,050 | +34.20% | ||
| 2023-05-18 | Sale | director | 50,000 0.05% | $3.89 | $194,500 | +32.02% | ||
| 2023-05-12 | Chief Executive Officer | 440,000 0.4311% | $3.40 | $1.5M | +48.00% |
Insider Historical Profitability
| FOEHR MATTHEW W | President and CEO | 3714447 3.0695% | $3.50 | 7 | 1 | +31.17% |
Institutional Investor Ownership
| Janus Henderson | $42.6M | 6.68 | 7.86M | +1.05% | +$441,946.68 | 0.02 | |
| BlackRock | $38.33M | 6.01 | 7.07M | -2.96% | -$1.17M | <0.01 | |
| The Vanguard Group | $30.97M | 4.86 | 5.71M | +1.1% | +$336,750.02 | <0.01 | |
| Macquarie Group | $18.83M | 2.95 | 3.47M | -2.64% | -$510,032.65 | 0.02 | |
| William Blair Investment Management | $18.23M | 2.86 | 3.36M | +0.81% | +$146,909.10 | 0.05 |